Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

Structure of the helicase core of Werner helicase, a key target in microsatellite instability cancers

View ORCID ProfileJoseph A Newman, Angeline E Gavard, Simone Lieb, Madhwesh C Ravichandran, Katja Hauer, Patrick Werni, Leonhard Geist, View ORCID ProfileJark Böttcher, View ORCID ProfileJohn R Engen, Klaus Rumpel, Matthias Samwer, View ORCID ProfileMark Petronczki, View ORCID ProfileOpher Gileadi  Correspondence email
Joseph A Newman
1Structural Genomics Consortium, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph A Newman
Angeline E Gavard
1Structural Genomics Consortium, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Lieb
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhwesh C Ravichandran
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Hauer
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Werni
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonhard Geist
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jark Böttcher
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jark Böttcher
John R Engen
3Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John R Engen
Klaus Rumpel
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Samwer
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Petronczki
2Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Petronczki
Opher Gileadi
1Structural Genomics Consortium, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Opher Gileadi
  • For correspondence: opher.gileadi@cmd.ox.ac.uk
Published 16 November 2020. DOI: 10.26508/lsa.202000795
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. ATP hydrolysis by WRN is essential for viability and genome integrity in MSI-H CRC cells.

    (A) Schematic representing the WRN domain structure. Location of nuclease-dead and ATPase-inactivating mutations (Walker A and B mutants) in siRNA-resistant WRN expression constructs containing a C-terminal 3xFLAG tag (WRNr) are indicated. (B) Monoclonal HCT 116 (MSI-H) cell clones were isolated after transduction with an empty vector control and WRNr wild-type or mutant transgenes. Immunoblotting of cell lysates with anti-FLAG and anti-WRN antibodies was used to determine the expression of the WRNr wild-type and mutant forms along with total WRN protein levels. Two WRNr wild-type clones (high and low) were selected to cover the expression range of WRNr mutant variants. (C) HCT 116 cells expressing WRNr transgenes were transfected with either non-targeting control or WRN siRNAs. Viability measurements were performed 7 d after siRNA transfection, and the data are represented relative to non-targeting control siRNA. Data information: In (C), viability data are shown as mean ± SD of three biological repeat experiments. (D) Immunofluorescence analysis of γ-H2AX was performed 72 h after siRNA transfection. The mean nuclear γH2AX intensity (a.u.) was quantified after siRNA transfection. Data points shown (n ≥ 120 cells per condition) are derived from a single representative experiment that is consistent with a biological repeat experiment. Scale bar, 20 μM. (E) Mitotic chromosome spread analysis was performed 72 h after siRNA transfection. At the 66 h time-point, cells were treated with 6 h of Nocodazole (1.5 μM) before spreading to enrich for mitotic stages. As a reference, some chromosome breaks are highlighted by red arrowheads. Each mitotic spread was categorized into less than five breaks or more than five breaks (n ≥ 28 mitotic spreads per condition). Data values and error bars presented here are the mean and the SD, respectively, from biological repeats (n = 2). Scale bar, 10 μM.

    Source data are available for this figure.

    Source Data for Figure 1[LSA-2020-00795_SdataF1.jpg]

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1.

    WRN expression and DNA damage in engineered cell lines. (A) To monitor cellular expression and nuclear accumulation of the WRNr transgenes, an anti-FLAG immunofluorescence analysis was performed in monoclonal cell lines expressing wild-type and mutant variants of WRNr. Scale bar, 20 μM. (B) Representative images of the immunofluorescence analysis of γ-H2AX that was performed 72 h after siRNA transfection. Scale bar, 20 μM. (C) Mitotic chromosome spread analysis was performed on each of the transgenic cell lines 72 h post-siRNA transfection that included a 6 h nocodazole (1.5 μM) treatment. Quantification was performed under a microscope where each mitotic spread was categorized into less than five (<5) breaks or more than five (>5) breaks (n ≥ 28 mitotic spreads). Data values and error bars presented here are the mean and the SD, respectively, from biological repeats (n = 2).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Structure of WRN helicase catalytic core and the nucleotide-binding site.

    (A) Overall structure of WRN helicase catalytic core with domains coloured individually. (B) Close-up view of the WRN nucleotide-binding site with conserved helicase motifs and key residues labelled. (C) Close-up view of the contact formed and interface between the D1 and D2 domains with key residues and motifs labelled.

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2.

    Details of nucleotide binding and comparisons with other human RecQ helicases. (A) Comparison of the nucleotide binding modes of WRN (left), RECQL5 (centre), and BLM (right) helicases. The nucleotide in the WRN structure is bound with extensive contacts from motif VI, whereas contacts from motif I are less extensive than in other RecQ helicase structures. (B) WRN electron density maps, the final 2Fo-1Fc electron density map is shown in grey in the vicinity of the nucleotide-binding site contoured at 1.2σ. A Fo-Fc difference map is show in green contoured at 2.7σ. This map was calculated with the side chain of R857 omitted from the model used for map calculation. (C) Close-up view of the WRN-specific β-hairpin insertion within the D2 domain, the hydrogen bond formed from the type II′ β-turn is show in yellow dashes.

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3. Global comparison of RecQ family relative domain positioning of D1 and D2.

    The upper panel shows a structural superposition of selected RecQ family structures on the basis of the D1 domain (left) or D2 domain (right). Invariant points used to define the positioning of the two domains are depicted as red spheres with numbering according to the WRN sequence. The lower panel shows a 2D vector diagram of distances between the vector pairs. The WRN structure occupies a distinct position at the bottom of the plot with a conformation even more compact that the APO form structures.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Comparison of WRN with other members of the RecQ family.

    (A) Comparison of current RecQ helicase structures superposed on the basis of the D1 domain (left) and D2 domain (right). (B) Comparison of the relative positioning of the winged hHelix domain with respect to the helicase core in various RecQ family structures, alignments were performed on the basis of the D2 domain with BLM-nanobody (NB) complex versus BLM-DNA complex shown on the left, D.r RecQ versus C.s RecQ-DNA complex in the centre and RecQ1–DNA complex shown on the right. The WRN Winged Helix domain is shown throughout in semi-transparent blue.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Examination of possible contacts between the WRN HRDC domain and helicase core.

    (A) Structural model of the possible WRN HRDC domain–helicase core interaction interface created by positioning the isolated WRN HRDC structure into its expected position based on the BLM helicase structure. (B) Superposition of 2D 15N SoFast HMQC spectra of 30 μM 15N-labelled WRN HRDC in absence (blue) or presence (red) of 250 μM unlabelled WRN helicase (residues 531–950). Resonances with a strong intensity decrease are highlighted. (C) Mapping of the interaction site between the WRN HRDC domain and the helicase core by NMR. Residues whose resonance is strongly affected by the interaction with the helicase domain are highlighted in red. Residues which could not be assigned are highlighted in white. All residues within 4 Å of a helicase core residue in our model are shown in stick format. The left-hand panel shows the HRDC domain in the same orientation as in section A, whereas the right-hand panel shows an orthogonal view with the interface.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. A model of WRN bound to DNA containing a 3′ overhang.

    (A) Overview of the WRN DNA model with predicted DNA contacting residues and motifs labelled. (B) Comparison of the zinc-binding domain in BLM (green) and WRN (pink) helicases and its contacts to the 3′ DNA overhang (shown in black stick format), the WRN Zn-binding domain features an extended linker helix, alternate positioning of Zn coordinating residues, and coil conformation of the N-terminal arm of the helical hairpin. Side chain residues from the helical hairpin that form contacts to DNA in the BLM structure are shown in stick format for reference.

  • Figure S4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S4. Comparison of current RecQ family DNA complex structures.

    The double-stranded part of the DNA is positioned variably with respect to the D2 domain, whereas the single-stranded 3′ overhang can be seen to converge an makes conserved interactions with helicase motifs IV and V.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6. Hydrogen deuterium exchange MS measurements of WRN in solution.

    (A) Comparative HDX (DAMP-PNP–Dunbound) of WRN in complex with the ATP analogue AMP-PNP mapped onto the WRN structure. Protection can be seen for nucleotide-binding features in D1 (left), whilst protection for nucleotide contacting residues from D2 are observed over longer time scales (right). (B) Comparative HDX of WRN (DssDNA–Dunbound) in complex with single-stranded DNA, mapped on to the WRN DNA-binding model. Protection can be seen for residues in the D2 hairpin and motif IV.

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1.

    Data collection and refinement statistics.

    WRN ADP
     Space groupP 21 21 21
     Cell dimensions a, b, c (Å)54.6, 90.6, 138.2
     Angles α, β, γ (°)90, 90, 90
     Wavelength (Å)1.08
     Resolution (Å)76.0–2.20 (2.26–2.20)
     Rmerge0.13 (2.3)
     Rp.i.m.0.06 (1.13)
     I/σI5.3 (1.0)
     CC1/20.99 (0.50)
     Completeness (%)98.8 (96.0)
     Multiplicity5.5 (5.5)
     No. of unique reflections35,356 (2,943)
    Refinement statistics
     Resolution76.0–2.20
     Rwork/Rfree (%)19.6/23.5
    No. of atoms
     Protein4,302
     Solvent195
     Ligand/ion29
    Average B factors (Å2)
     Protein71.8
     Solvent68.8
     Ligand/ion76
     Wilson B48
    RMSD
     Bond lengths (Å)0.002
     Bond angles (°)0.534
    Ramachandran plot
     Favoured (%)97.3
     Allowed (%)2.7

Supplementary Materials

  • Figures
  • Tables
  • Table S1 HDX data summary and list of experimental parameters.

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Structure of the helicase core of Werner helicase, a key target in microsatellite instability cancers
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Crystal structure of Werner syndrome helicase core domain
Joseph A Newman, Angeline E Gavard, Simone Lieb, Madhwesh C Ravichandran, Katja Hauer, Patrick Werni, Leonhard Geist, Jark Böttcher, John R Engen, Klaus Rumpel, Matthias Samwer, Mark Petronczki, Opher Gileadi
Life Science Alliance Nov 2020, 4 (1) e202000795; DOI: 10.26508/lsa.202000795

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Crystal structure of Werner syndrome helicase core domain
Joseph A Newman, Angeline E Gavard, Simone Lieb, Madhwesh C Ravichandran, Katja Hauer, Patrick Werni, Leonhard Geist, Jark Böttcher, John R Engen, Klaus Rumpel, Matthias Samwer, Mark Petronczki, Opher Gileadi
Life Science Alliance Nov 2020, 4 (1) e202000795; DOI: 10.26508/lsa.202000795
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 4, No. 1
January 2021
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Data Availability
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Cancer
  • Structural Biology

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Interaction hub for telomerase function
  • Toxoplasma OTU deubiquitinases
  • Iodine-induced cellular toxicity
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2023 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.